BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

552 related articles for article (PubMed ID: 31530463)

  • 1. Have Venous Thromboembolism Rates Decreased in Total Hip and Knee Arthroplasty?
    Warren JA; Sundaram K; Anis HK; Kamath AF; Higuera CA; Piuzzi NS
    J Arthroplasty; 2020 Jan; 35(1):259-264. PubMed ID: 31530463
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is Obesity Associated With Increased Risk of Deep Vein Thrombosis or Pulmonary Embolism After Hip and Knee Arthroplasty? A Large Database Study.
    Sloan M; Sheth N; Lee GC
    Clin Orthop Relat Res; 2019 Mar; 477(3):523-532. PubMed ID: 30624321
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Venous Thromboembolism Rates Did Not Decrease in Lower Extremity Revision Total Joint Arthroplasty From 2008 to 2016.
    Warren JA; Sundaram K; Kamath AF; Molloy RM; Krebs VE; Mont MA; Piuzzi NS
    J Arthroplasty; 2019 Nov; 34(11):2774-2779. PubMed ID: 31153709
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Venous thromboembolism is rare after total hip and knee joint arthroplasty with long thromboprophylaxis in Finnish fast-track hospitals.
    Moisander AM; Pamilo K; Eskelinen A; Huopio J; Kautiainen H; Kuitunen A; Paloneva J
    Arch Orthop Trauma Surg; 2023 Sep; 143(9):5623-5629. PubMed ID: 37067559
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Incidence and Economic Burden of In-Hospital Venous Thromboembolism in the United States.
    Shahi A; Chen AF; Tan TL; Maltenfort MG; Kucukdurmaz F; Parvizi J
    J Arthroplasty; 2017 Apr; 32(4):1063-1066. PubMed ID: 27866951
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological thromboprophylaxis and its impact on venous thromboembolism following total knee and hip arthroplasty in Korea: A nationwide population-based study.
    Yhim HY; Lee J; Lee JY; Lee JO; Bang SM
    PLoS One; 2017; 12(5):e0178214. PubMed ID: 28542415
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The incidence of symptomatic in-hospital VTEs in Asian patients undergoing joint arthroplasty was low: a prospective, multicenter, 17,660-patient-enrolled cohort study.
    Zeng Y; Si H; Wu Y; Yang J; Zhou Z; Kang P; Pei F; Shen B
    Knee Surg Sports Traumatol Arthrosc; 2019 Apr; 27(4):1075-1082. PubMed ID: 30386998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factor Xa Inhibitors and Direct Thrombin Inhibitors Versus Low-Molecular-Weight Heparin for Thromboprophylaxis After Total Hip or Total Knee Arthroplasty: A Systematic Review and Meta-Analysis.
    Sun G; Wu J; Wang Q; Liang Q; Jia J; Cheng K; Sun G; Wang Z
    J Arthroplasty; 2019 Apr; 34(4):789-800.e6. PubMed ID: 30685261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prior COVID-19 and Venous Thromboembolism Risk in Total Joint Arthroplasty in Patients Over 65 Years of Age.
    Okewunmi JO; Ren R; Zubizarreta N; Kodali H; Poeran J; Hayden BL; Chen DD; Moucha CS
    J Arthroplasty; 2024 Mar; 39(3):819-824.e1. PubMed ID: 37757982
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors for venous thromboembolism in patients with diabetes undergoing joint arthroplasty.
    Deng W; Huo L; Yuan Q; Huang D; Li Q; Tian W
    BMC Musculoskelet Disord; 2021 Jul; 22(1):608. PubMed ID: 34229632
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thirty day low-dose versus regular-dose aspirin for venous thromboembolism prophylaxis in primary total joint arthroplasty.
    Duke AJ; Bowen S; Baig S; Cohen D; Komatsu DE; Nicholson J
    J Orthop Surg (Hong Kong); 2023; 31(2):10225536231173329. PubMed ID: 37137821
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors for venous thromboembolism after total hip and total knee arthroplasty: a meta-analysis.
    Zhang J; Chen Z; Zheng J; Breusch SJ; Tian J
    Arch Orthop Trauma Surg; 2015 Jun; 135(6):759-72. PubMed ID: 25854654
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Venous thromboembolism after total joint arthroplasty: results from a Japanese multicenter cohort study.
    Migita K; Bito S; Nakamura M; Miyata S; Saito M; Kakizaki H; Nakayama Y; Matsusita T; Furuichi I; Sasazaki Y; Tanaka T; Yoshida M; Kaneko H; Abe I; Mine T; Ihara K; Kuratsu S; Saisho K; Miyahara H; Segata T; Nakagawa Y; Kamei M; Torigoshi T; Motokawa S
    Arthritis Res Ther; 2014 Jul; 16(4):R154. PubMed ID: 25047862
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Venous thromboembolism rates after hip and knee arthroplasty and hip fractures.
    Mula V; Parikh S; Suresh S; Bottle A; Loeffler M; Alam M
    BMC Musculoskelet Disord; 2020 Feb; 21(1):95. PubMed ID: 32050949
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bleeding and thromboembolism risk of standard antithrombotic prophylaxis after hip or knee replacement within an enhanced recovery program.
    Jenny JY; Bulaid Y; Boisrenoult P; Bonin N; Henky P; Tracol P; Chouteau J; Courtin C; Henry MP; Schwartz C; Mertl P; De Ladoucette A;
    Orthop Traumatol Surg Res; 2020 Dec; 106(8):1533-1538. PubMed ID: 33127330
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Venous Thromboembolism despite Ongoing Prophylaxis after Fast-Track Hip and Knee Arthroplasty: A Prospective Multicenter Study of 34,397 Procedures.
    Petersen PB; Jørgensen CC; Kehlet H;
    Thromb Haemost; 2019 Nov; 119(11):1877-1885. PubMed ID: 31587249
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is Apixaban Safe and Effective for Venous Thromboembolism Prophylaxis After Primary Total Hip and Total Knee Arthroplasties?
    Rooney T; Barrack RL; Clohisy JC; Nunley RM; Lawrie CM
    J Arthroplasty; 2021 Jul; 36(7S):S328-S331. PubMed ID: 33888386
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety of In-Hospital Only Thromboprophylaxis after Fast-Track Total Hip and Knee Arthroplasty: A Prospective Follow-Up Study in 17,582 Procedures.
    Petersen PB; Kehlet H; Jørgensen CC;
    Thromb Haemost; 2018 Dec; 118(12):2152-2161. PubMed ID: 30453352
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aspirin for Venous Thromboembolic Prophylaxis Following Total Hip and Total Knee Arthroplasty: An Analysis of Safety and Efficacy Accounting for Surgeon Selection Bias.
    Heckmann ND; Piple AS; Wang JC; Richardson MK; Mayfield CK; Oakes DA; Christ AB; Lieberman JR
    J Arthroplasty; 2023 Jul; 38(7 Suppl 2):S412-S419.e1. PubMed ID: 36870517
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness and safety of rivaroxaban for the prevention of thrombosis following total hip or knee replacement: A systematic review and meta-analysis.
    Liu J; Zhao J; Yan Y; Su J
    Medicine (Baltimore); 2019 Mar; 98(9):e14539. PubMed ID: 30817570
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.